Unlocking Bacteriophage Potential

PrecisionPhage is a Finland-based biotech company specializing in phage technologies.

We provide bioinformatic analyses, phage licensing and laboratory services.

What are bacteriophages?
bacteriophage

What are bacteriophages?

...or 'phages' for short

Phages are viruses that attack bacteria

They are natural predators of bacteria – and can be used to combat infections.
  • Precision. Unlike antibiotics, phages only attack their target bacteria
  • Diversity. There is likely a phage for every bacterium out there, even for the antibiotic-resistant ones
  • Flexibility and evolvability. Phages can be combined to a "phage cocktail" against which bacterial resistance is less likely to develop. Phages can also be evolved to target a specific bacterial strain.

Products and services

We offer computational and laboratory-based phage services

Software

Phagenomics

Analyse phage genomes swiftly and accurately with our cloud-based, user-friendly software.

  • Genome assembly. Submit your raw sequencing reads to our automated assembly pipeline.

  • Genome analysis. Analyse your newly assembled phage genome for its suitability for phage therapy or other purposes. Alternatively, submit your own assembly.

  • Comparative genomics True analytical power comes from comparison. Compare phage attributes and create heatmaps, alignments and other comparative genomic analyses in the browser.


Go to Phagenomics

Phage collection

We have been building a phage collection for more than ten years, now spanning over 1,500 strains.

The main targets of the collection include, but are not limited to:

  • Escherichia coli

  • Klebsiella pneumoniae

  • Pseudomonas aeruginosa

  • Acinetobacter baumannii

We can screen your bacterium against our collection to find suitable phages for your purpose
Our phages are available for exclusive or non-exclusive licensing

Phage laboratory services

Our Finland-based, state-of-the-art laboratory is equipped to provide a range of phage services, including:

  • On-demand phage isolation ?

    If there is no compatible phage in our collection, we can always go phage hunting for you! The isolated phages can be licensed or purchased based on the established contracts. At the moment this service is limited to bacterial species and strains of biosafety-level (BSL) 2 (or below) bacteria. For a substantial number of BSL3 strains, we offer options for developmental cooperation.

  • Small-scale phage production
  • Sequencing
  • Customised genomic analyses
Don't hesitate to get in touch with us to discuss your needs!
Contact us

UPDATES

04.04.2024
PrecisionPhage wins Tahko Ski Lift Pitch competition (in Finnish)

"PrecisionPhage has almost limitless scalability potential and a socially impacting business idea. In addition, the company stood out from the competition from the start with impressive pitching," the members of the jury summarize.
20.01.2023
Unifund invests in PrecisionPhage (in Finnish)
03.02.2023
Phages an alternative for antibiotics? Talouselämä covers PrecisionPhage (in Finnish)
23.01.2023
Phages as weapons against antibiotic resistant bacteria – Kemiamedia covers PrecisionPhage (in Finnish)

Invest in PrecisionPhage

We warmly welcome potential investors. To learn more about investment opportunities, please contact us.

Contact us

Team

PrecisionPhage management and employees have extensive backgrounds in bacteriophage research.

Management

Matti Jalasvuori, PhD, Dos.

Chief Executive Officer (CEO)

Liisa Chisty, PhD

Chief Business Officer (CBO)

Ville Hoikkala, PhD

Chief Bioinformatician

Saija Kiljunen, PhD, Dos.

Chief Scientific Officer

Employees

Juuli Peräkylä

Laboratory Technician

Tiia Eklund

Laboratory Technician

Sanna Vacker

Laboratory Technician

Olli Pitkänen

Chief Development Officer

Contact

We are located in Jyväskylä, central Finland. Drop us a message below or give us a call!

Location:

Survontie 9, 40500 Jyväskylä, Finland

Call:

+358 50413 5092

We are currently updating our contact form. In the meantime, please contact us via email.